Skip to content

Clinical trials

Phase 2 Fallopian Tube Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 2 Country / region: United States Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20025
20038
20044
20058
200618
200711
20089
20097
201019
20117
201210
20136
20144
20158
201611
20179
20183
20196
20203
20215
20225
20238
20244
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Terminated34
Recruiting19
Active, not recruiting19
Unknown status8
Withdrawn4
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)37
Gynecologic Oncology Group13
M.D. Anderson Cancer Center11
Dana-Farber Cancer Institute10
Memorial Sloan Kettering Cancer Center9
Mayo Clinic6
AbbVie5
Roswell Park Cancer Institute5
Masonic Cancer Center, University of Minnesota4
University of Washington4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms210
Ovarian Neoplasms176
Carcinoma, Ovarian Epithelial79
Endometrial Neoplasms15
Neoplasms13
Brenner Tumor11
Uterine Cervical Neoplasms11
Peritoneal Neoplasms9
Breast Neoplasms8
Recurrence8

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.